Therapeutic opportunities in the B7/CD28 family of ligands and receptors

Current Opinion in Pharmacology

Volumn 5, Issue 4 SPEC. ISS., 2005, Pages 424-430

  Carreno, Beatriz M ^a   Carter, Laura L ^a   Collins, Mary ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INDUCIBLE COSTIMULATOR; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; METHOTREXATE; PROGRAMMED CELL DEATH 1; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

CANCER; CLINICAL TRIAL; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG TARGETING; ENTEROPATHY; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATORY DISEASE; LIVER DISEASE; MELANOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN TARGETING; PSORIASIS VULGARIS; REVIEW; RHEUMATOID ARTHRITIS; SKIN DISEASE; T LYMPHOCYTE ACTIVATION;

EID: 21644446452     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.02.003     Document Type: Review

References (74)

1. B.M. Carreno M. Collins The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses Annu Rev Immunol 20 2002 29-53
2. J.L. Riley C.H. June The CD28 family: A T-cell rheostat for therapeutic control of T-cell activation Blood 105 2005 13-21
3. R.J. Greenwald G.J. Freeman A.H. Sharpe The B7 family revisited Annu Rev Immunol 23 2005 515-548
4. J.R. Sedy M. Gavrieli K.G. Potter M.A. Hurchla R.C. Lindsley K. Hildner S. Scheu K. Pfeffer C.F. Ware T.L. Murphy et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator Nat Immunol 6 2005 90-98
5. M. Sun S. Richards D.V. Prasad X.M. Mai A. Rudensky C. Dong Characterization of mouse and human B7-H3 genes J Immunol 168 2002 6294-6297
6. D.V. Prasad T. Nguyen Z. Li Y. Yang J. Duong Y. Wang C. Dong Murine B7-H3 is a negative regulator of T cells J Immunol 173 2004 2500-2506
7. V. Ling P.W. Wu V. Spaulding J. Kieleczawa D. Luxenberg B.M. Carreno M. Collins Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: Divergent history of functional redundancy and exon loss Genomics 82 2003 365-377
8. D.V. Prasad S. Richards X.M. Mai C. Dong B7S1, a novel B7 family member that negatively regulates T cell activation Immunity 18 2003 863-873
9. G.L. Sica I.H. Choi G. Zhu K. Tamada S.D. Wang H. Tamura A.I. Chapoval D.B. Flies J. Bajorath L. Chen B7-H4, a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 2003 849-861
10. X. Zang P. Loke J. Kim K. Murphy R. Waitz J.P. Allison B7x: A widely expressed B7 family member that inhibits T cell activation Proc Natl Acad Sci USA 100 2003 10388-10392
11. B. Salomon J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol 19 2001 225-252
12. M.K. Racke D.E. Scott L. Quigley G.S. Gray R. Abe C.H. June P.J. Perrin Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis J Clin Invest 96 1995 2195-2203
13. Q. Tang K.J. Henriksen E.K. Boden A.J. Tooley J. Ye S.K. Subudhi X.X. Zheng T.B. Strom J.A. Bluestone Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells J Immunol 171 2003 3348-3352
14. B. Salomon D.J. Lenschow L. Rhee N. Ashourian B. Singh A. Sharpe J.A. Bluestone B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes Immunity 12 2000 431-440
15. J.R. Abrams M.G. Lebwohl C.A. Guzzo B.V. Jegasothy M.T. Goldfarb B.S. Goffe A. Menter N.J. Lowe G. Krueger M.J. Brown et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris J Clin Invest 103 1999 1243-1252
16. J.M. Kremer R. Westhovens M. Leon E. Di Giorgio R. Alten S. Steinfeld A. Russell M. Dougados P. Emery I.F. Nuamah et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig N Engl J Med 349 2003 1907-1915
17. C.A. Chambers M.S. Kuhns J.G. Egen J.P. Allison CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy Annu Rev Immunol 19 2001 565-594
18. G.Q. Phan J.C. Yang R.M. Sherry P. Hwu S.L. Topalian D.J. Schwartzentruber N.P. Restifo L.R. Haworth C.A. Seipp L.J. Freezer et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc Natl Acad Sci USA 100 2003 8372-8377
19. K. Sanderson R. Scotland P. Lee D. Liu S. Groshan J. Snively S. Sian G. Nichol T. Davis T. Keler et al. Autoimmunity in a Phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stages III and IV melanoma J Clin Oncol 23 2005 741-750
20. A. Dols J.W. Smith II S.L. Meijer B.A. Fox H.M. Hu E. Walker S. Rosenheim T. Moudgil T. Doran W. Wood et al. Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: Clinical and immunological results Hum Gene Ther 14 2003 1117-1123
21. S.J. Antonia J. Seigne J. Diaz C. Muro-Cacho M. Extermann M.J. Farmelo M. Friberg M. Alsarraj J.J. Mahany J. Pow-Sang et al. Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma J Urol 167 2002 1995-2000
22. L.E. Raez P.A. Cassileth J.J. Schlesselman S. Padmanabhan E.Z. Fisher P.A. Baldie K. Sridhar E.R. Podack Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma Cancer Gene Ther 10 2003 850-858
23. L.E. Raez P.A. Cassileth J.J. Schlesselman K. Sridhar S. Padmanabhan E.Z. Fisher P.A. Baldie E.R. Podack Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer J Clin Oncol 22 2004 2800-2807
24. U. Grohmann C. Orabona F. Fallarino C. Vacca F. Calcinaro A. Falorni P. Candeloro M.L. Belladonna R. Bianchi M.C. Fioretti et al. CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097-1101
25. A. Boasso J.P. Herbeuval A.W. Hardy C. Winkler G.M. Shearer Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells Blood 105 2005 1574-1581
26. T. Birsan B. Hausen J.P. Higgins R.W. Hubble J. Klupp M. Stalder A. Celniker S. Friedrich R.M. O'Hara R.E. Morris Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys Transplantation 75 2003 2106-2113
27. C. Orabona U. Grohmann M.L. Belladonna F. Fallarino C. Vacca R. Bianchi S. Bozza C. Volpi B.L. Salomon M.C. Fioretti et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 Nat Immunol 5 2004 1134-1142
28. P. Huxley D.H. Sutton P. Debnam I.R. Matthews J.E. Brewer J. Rose M. Trickett D.D. Williams T.B. Andersen B.J. Classon High-affinity small molecule inhibitors of T cell costimulation: Compounds for immunotherapy Chem Biol 11 2004 1651-1658
29. N.J. Green J. Xiang J. Chen L. Chen A.M. Davies D. Erbe S. Tam J.F. Tobin Structure-activity studies of a series of dipyrazolo[3,4-b:3′,4'-d]pyridin-3-ones binding to the immune regulatory protein B7. 1 Bioorg Med Chem 11 2003 2991-3013
30. C. Dong A.E. Juedes U.A. Teman S. Shresta J.P. Allison N.H. Ruddle R.A. Flavell ICOS co-stimulatory receptor is essential for T cell activation and function Nature 409 2001 97-101
31. A. Tafuri A. Shahinian F. Bladt S.K. Yoshinaga M. Jordana A. Wakeham L.M. Boucher D. Bouchard Chan VSF G. Duncan et al. ICOS is essential for effective T-helper-cell responses Nature 409 2001 105-109
32. A.J. McAdam R.J. Greenwald M.A. Levin T. Chernova N. Malenkovich V. Ling G.J. Freeman A.H. Sharpe ICOS is critical for CD40-mediated antibody class switching Nature 409 2001 102-104
33. U. Salzer A. Maul-Pavicic C. Cunningham-Rundles S. Urschel B.H. Belohradsky J. Litzman A. Holm J.L. Franco A. Plebani L. Hammarstrom et al. ICOS deficiency in patients with common variable immunodeficiency Clin Immunol 113 2004 234-240
34. B. Grimbacher A. Hutloff M. Schlesier E. Glocker K. Warnatz R. Drager H. Eibel B. Fischer A.A. Schaffer H.W. Mages et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency Nat Immunol 4 2003 261-268
35. R.I. Nurieva P. Treuting J. Duong R.A. Flavell C. Dong Inducible costimulator is essential for collagen-induced arthritis J Clin Invest 111 2003 701-706
36. H. Iwai Y. Kozono S. Hirose H. Akiba H. Yagita K. Okumura H. Kohsaka N. Miyasaka M. Azuma Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation J Immunol 169 2002 4332-4339
37. H. Iwai M. Abe S. Hirose F. Tsushima K. Tezuka H. Akiba H. Yagita K. Okumura H. Kohsaka N. Miyasaka et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis J Immunol 171 2003 2848-2854
38. R.A. Sporici R.L. Beswick C. von Allmen C.A. Rumbley M. Hayden-Ledbetter J.A. Ledbetter P.J. Perrin ICOS ligand costimulation is required for T-cell encephalitogenicity Clin Immunol 100 2001 277-288
39. J.B. Rottman T. Smith J.R. Tonra K. Ganley T. Bloom R. Silva B. Pierce J.C. Gutierrez-Ramos E. Ozkaynak A.J. Coyle The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE Nat Immunol 2 2001 605-611
40. A.E. Herman G.J. Freeman D. Mathis C. Benoist CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion J Exp Med 199 2004 1479-1489
41. S.J. Khoury M.H. Sayegh The roles of the new negative T cell costimulatory pathways in regulating autoimmunity Immunity 20 2004 529-538
42. H. Nishimura M. Nose H. Hiai N. Minato T. Honjo Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 11 1999 141-151
43. H. Nishimura T. Okazaki Y. Tanaka K. Nakatani M. Hara A. Matsumori S. Sasayama A. Mizoguchi H. Hial N. Minato et al. Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice Science 291 2001 319-322
44. B.R. Blazar B.M. Carreno A. Panoskaltsis-Mortari L. Carter Y. Iwai H. Yagita H. Nishimura P.A. Taylor Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism J Immunol 171 2003 1272-1277
45. A.D. Salama T. Chitnis J. Imitola M.J. Ansari H. Akiba F. Tushima M. Azuma H. Yagita M.H. Sayegh S.J. Khoury Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis J Exp Med 198 2003 71-78
46. M.J. Ansari A.D. Salama T. Chitnis R.N. Smith H. Yagita H. Akiba T. Yamazaki M. Azuma H. Iwai S.J. Khoury et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice J Exp Med 198 2003 63-69
47. Y. Iwai S. Terawaki T. Honjo PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells Int Immunol 17 2005 133-144
48. T. Kanai T. Totsuka K. Uraushihara S. Makita T. Nakamura K. Koganei T. Fukushima H. Akiba H. Yagita K. Okumura et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation J Immunol 171 2003 4156-4163
49. S.K. Subudhi P. Zhou L.M. Yerian R.K. Chin J.C. Lo R.A. Anders Y. Sun L. Chen Y. Wang M.L. Alegre et al. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection J Clin Invest 113 2004 694-700
50. S. Wang J. Bajorath D.B. Flies H. Dong T. Honjo L. Chen Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction J Exp Med 197 2003 1083-1091
51. T. Shin G. Kennedy K. Gorski H. Tsuchiya H. Koseki M. Azuma H. Yagita L. Chen J. Powell D. Pardoll et al. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor J Exp Med 198 2003 31-38
52. P. Loke J.P. Allison PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells Proc Natl Acad Sci USA 100 2003 5336-5341
53. K. Matsumoto H. Inoue T. Nakano M. Tsuda Y. Yoshiura S. Fukuyama F. Tsushima T. Hoshino H. Aizawa H. Akiba et al. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism J Immunol 172 2004 2530-2541
54. E. Oflazoglu D.A. Swart P. Anders-Bartholo H.K. Jessup A.M. Norment W.A. Lawrence K. Brasel J.E. Tocker T. Horan A.A. Welcher et al. Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo Eur J Immunol 34 2004 3326-3336
55. A.I. Chapoval J. Ni J.S. Lau R.A. Wilcox D.B. Flies D. Liu H. Dong G.L. Sica G. Zhu K. Tamada et al. B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production Nat Immunol 2 2001 269-274
56. P. Steinberger O. Majdic S.V. Derdak K. Pfistershammer S. Kirchberger C. Klauser G. Zlabinger W.F. Pickl J. Stockl W. Knapp Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains J Immunol 172 2004 2352-2359
57. W.K. Suh B.U. Gajewska H. Okada M.A. Gronski E.M. Bertram W. Dawicki G.S. Duncan J. Bukczynski S. Plyte A. Elia et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nat Immunol 4 2003 899-906
58. R. Castriconi A. Dondero R. Augugliaro C. Cantoni B. Carnemolla A.R. Sementa F. Negri R. Conte M.V. Corrias L. Moretta et al. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc Natl Acad Sci USA 101 2004 12640-12645
59. X. Sun M. Vale E. Leung J.R. Kanwar R. Gupta G.W. Krissansen Mouse B7-H3 induces antitumor immunity Gene Ther 10 2003 1728-1734
60. L. Luo A.I. Chapoval D.B. Flies G. Zhu F. Hirano S. Wang J.S. Lau H. Dong K. Tamada A.S. Flies et al. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells J Immunol 173 2004 5445-5450
61. W.K. Suh S.X. Wang A.H. Jheon L. Moreno S.K. Yoshinaga B. Ganss J. Sodek M.D. Grynpas T.W. Mak The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization Proc Natl Acad Sci USA 101 2004 12969-12973
62. P. Loke J.P. Allison Emerging mechanisms of immune regulation: The extended B7 family and regulatory T cells Arthritis Res Ther 6 2004 208-214
63. J.A. Brown D.M. Dorfman F.R. Ma E.L. Sullivan O. Munoz C.R. Wood E.A. Greenfield G.J. Freeman Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 2003 1257-1266
64. Y. Agata A. Kawasaki H. Nishimura Y. Ishida T. Tsubata H. Yagita T. Honjo Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes Int Immunol 8 1996 765-772
65. M.J. Eppihimer J. Gunn G.J. Freeman E.A. Greenfield T. Chernova J. Erickson J.P. Leonard Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells Microcirculation 9 2002 133-145
66. J. Konishi K. Yamazaki M. Azuma I. Kinoshita H. Dosaka-Akita M. Nishimura B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clin Cancer Res 10 2004 5094-5100
67. M.M. Mazanet C.C. Hughes B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis J Immunol 169 2002 3581-3588
68. A. Nakazawa I. Dotan J. Brimnes M. Allez L. Shao F. Tsushima M. Azuma L. Mayer The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells Gastroenterology 126 2004 1347-1357
69. N. Rodig T. Ryan J.A. Allen H. Pang N. Grabie T. Chernova E.A. Greenfield S.C. Liang A.H. Sharpe A.H. Lichtman et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis Eur J Immunol 33 2003 3117-3126
70. B. Saatian X. Yu A.P. Lane T. Doyle V. Casolaro E.W. Spannhake Expression of genes for B7-H3 and other T cell ligands by nasal epithelial cells during differentiation and activation Am J Physiol Lung Cell Mol Physiol 287 2004 L217-L225
71. R. Schoop P. Wahl M. Le Hir U. Heemann M. Wang R.P. Wuthrich Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells Nephrol Dial Transplant 19 2004 2713-2720
72. P. Youngnak-Piboonratanakit F. Tsushima N. Otsuki H. Igarashi U. Machida H. Iwai Y. Takahashi K. Omura H. Yokozeki M. Azuma The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role Immunol Lett 94 2004 215-222
73. X. Tai M. Cowan L. Feigenbaum A. Singer CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2 Nat Immunol 6 2005 152-162
74. L. Wang C.C. Fraser K. Kikly A.D. Wells R. Han A.J. Coyle L. Chen W.W. Hancock B7-H3 promotes acute and chronic allograft rejection Eur J Immunol 35 2005 428-438